Veterinary Medicines

AFTOVAXPUR 3 ML SUSPENSION INJECTABLE POUR BOVINS ET OVINS

Authorised
  • Foot-and-mouth disease virus, serotype SAT2, strain Eri, Inactivated
  • Foot-and-mouth disease virus, serotype A, strain A22 Iraq, Inactivated
  • Foot-and-mouth disease virus, serotype O, strain O1 Manisa, Inactivated
  • Foot-and-mouth disease virus, serotype Asia 1, strain Shamir, Inactivated
Download as PDF

Product identification

Medicine name:
AFTOVAXPUR 3 ML SUSPENSION INJECTABLE POUR BOVINS ET OVINS
Active substance:
  • Foot-and-mouth disease virus, serotype SAT2, strain Eri, Inactivated
  • Foot-and-mouth disease virus, serotype A, strain A22 Iraq, Inactivated
  • Foot-and-mouth disease virus, serotype O, strain O1 Manisa, Inactivated
  • Foot-and-mouth disease virus, serotype Asia 1, strain Shamir, Inactivated
Target species:
  • Cattle
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Foot-and-mouth disease virus, serotype SAT2, strain Eri, Inactivated
    6.00
    50% Protective Dose
    /
    3.00
    millilitre(s)
  • Foot-and-mouth disease virus, serotype A, strain A22 Iraq, Inactivated
    6.00
    50% Protective Dose
    /
    3.00
    millilitre(s)
  • Foot-and-mouth disease virus, serotype O, strain O1 Manisa, Inactivated
    6.00
    50% Protective Dose
    /
    3.00
    millilitre(s)
  • Foot-and-mouth disease virus, serotype Asia 1, strain Shamir, Inactivated
    6.00
    50% Protective Dose
    /
    3.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • All relevant tissues
        0
        day
    • Sheep
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AA04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/8748745 9/2019
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 30/10/2024
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 30/10/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."